Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.
Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express therapeutic genes that augment their anti-cancer activities. Modifying oncolytic viruses to produce effective cancer therapies is challenging as encoding transgenes often attenuates virus activity or pre...
Saved in:
| Main Authors: | Nalini Marino, Sam Illingworth, Prithvi Kodialbail, Ashvin Patel, Hugo Calderon, Rochelle Lear, Kerry D Fisher, Brian R Champion, Alice C N Brown |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0177810&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A versatile cell line for establishing potency of cell type-specific AAV transgenes
by: Refugio A. Martinez, et al.
Published: (2025-03-01) -
Phylogenetic quantification of intra-tumour heterogeneity.
by: Roland F Schwarz, et al.
Published: (2014-04-01) -
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment
by: Victoria A. Jennings, et al.
Published: (2024-12-01) -
Neutralizing monoclonal antibodies improve biodistribution of intravenously administered oncolytic adenovirus in human CD46-transgenic mice.
by: Masahisa Hemmi, et al.
Published: (2025-01-01) -
Intra-Diverticular Bladder Tumours: How to Manage Rationally
by: Mohammed Lotfi Amer, et al.
Published: (2022-09-01)